Discovering the true signals of disease to power life-changing medicines51-200 Employees
Sequence Bio careers
90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
Software Developer
In office • Canada
Matthew Stenback
Director of Application Development @Sequence Bio
David Phillips, CPA, CA
Michael S. Phillips
Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.
Valuation
$0
Funded over
1 round
Latest round